← Back
$RXRX All transactions

RECURSION PHARMACEUTICALS, INC.

C 10b5-1 Plan

$ Value

$0

Shares

40,000

Price

$0

Filed

Nov 19

Insider

Name

Gibson Christopher

Title

Chief Executive Officer

CIK

0001856369

Roles

Director Officer

Transaction Details

Transaction Date

2025-11-19

Code

C

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

4,823,334

Footnotes

Represents shares that have been withheld by the Issuer to satisfy its tax withholding and remittance obligations in connection with the net settlement of restricted stock units. | This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2025. | Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. | The shares are held by LAHWRAN-3 LLC, of which the Reporting Person is a member and a manager. | The shares are held by LAHWRAN-4 LLC, of which the Reporting Person is a member and a manager. | The shares are held by the Gibson Family Trust, of which the Reporting Person serves as Trustee. | The option vests as to one forty-eighth (1/48th) of the original 666,898 shares subject to the option on March 1, 2024, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter. | The option vests as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2025, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter. | The option vests as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2023, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter. | The option, originally for 416,350 shares, vested as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2022, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter. | The option, originally for 1,500,000 shares, vested as to one forty-eighth (1/48th) of the shares subject to the option on January 31, 2021, and one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter.

Filing Info

Accession No.

0001856369-25-000014

Form Type

4

Issuer CIK

0001601830

Gibson Christopher's History

Date Ticker Type Value
2026-04-08 PACB A $0
2026-04-08 PACB A $0
2026-04-07 RXRX C $0
2026-04-07 RXRX $124K
2026-04-07 RXRX C $0
2026-03-23 RXRX C $0
2026-03-23 RXRX $130K
2026-03-23 RXRX C $0
2025-12-19 RXRX C $0
2025-12-19 RXRX $180K

Other Insiders at RXRX (90d)

Insider Bought Sold Last
Taylor Ben R
Chief Financial Officer
2026-04-06
Li Dean Y 2026-04-01
Dar Zavain 2026-04-01
Borgeson Blake $93K 2026-04-07
Gibson Christopher $254K 2026-04-07